Cronos to enter the Netherlands with acquisition of Europe's largest adult-use cannabis company

Executive Summary

• Cronos Group Inc. announced a definitive agreement to acquire all outstanding shares of CanAdelaar B.V., the largest cannabis operator in the Netherlands’ adult‑use pilot program (“Wietexperiment”).
• The transaction includes an up‑front cash payment of €57.5 million (≈US$67.0 million) and contingent earn‑out payments equal to 0.5× CanAdelaar’s normalized EBITDA for each of 2026 and 2027.
• The deal values CanAdelaar at ~1.4× its last‑twelve‑month (LTM) revenue and ~2.4× LTM EBITDA, giving Cronos #1 market share in Europe’s largest adult‑use cannabis market and supporting its “borderless product” strategy.

Key Details

• Purchase Price – Up‑front: €57.5 million (≈US$67.0 million) payable in cash at closing, subject to customary adjustments.
• Earn‑out Consideration: Cash equal to 0.5× CanAdelaar’s normalized EBITDA for 2026 and again for 2027.
• Valuation Multiples: ~1.4× LTM revenue; ~2.4× LTM EBITDA (based on twelve months ended September 30, 2025).
• Closing Timeline: Transaction approved by Cronos’ Board; expected to close in early 2026 pending customary closing conditions and Dutch regulatory approvals.
• CanAdelaar Financials (LTM ending Sep 30 2025): Revenue US$47.3 million; EBITDA US$28.2 million. 2024 figures: revenue US$17.7 million; EBITDA US$8.0 million.
• Operational Highlights of CanAdelaar:
• Annual dried‑flower yield ≈20,000 kg from a 540,000 sq ft greenhouse/processing facility.
• Only industrial‑scale greenhouse cultivator among the ten licensed producers in the Wietexperiment.
• Serves all 72 coffee shops participating in the pilot program; leading market share by volume and revenue.
• Strategic Rationale for Cronos:
• Provides a foothold to achieve #1 market share in Europe’s largest adult‑use cannabis market.
• Enables “borderless product” strategy leveraging Cronos’ genetics, R&D, and brand portfolio across flower, pre‑rolls, hash, edibles, and vapes.
• Offers cost advantages via industrial‑scale greenhouse cultivation and potential expansion if the Dutch pilot program is broadened beyond ten municipalities.
• Regulatory Context: The Wietexperiment, launched April 7 2025, restricts import/export and inter‑producer sales; operates in ten municipalities covering 72 coffee shops (out of 562 nationwide). The Dutch government may extend the program up to an additional 18 months.
• Investor Materials: An investor presentation detailing the transaction is available on Cronos’ website under “Investor Relations.”

Notable Quotes

“Our acquisition of CanAdelaar is a financially compelling and highly strategic transaction that will establish a strategic footprint in Europe and enable us to leverage our investments in borderless products,” – Mike Gorenstein, Chairman, President & CEO, Cronos.